Learn bits
Health & Medicine
Pradeep Kumar

09/05/21 12:00 PM IST

WHO approves China’s Sinopharm vaccine

In news

The World Health Organization on approved the Sinopharm the first Chinese COVID-19 vaccine for emergency use 

Highlights

  • The UN health agency signed off on the two-dose vaccine, which is already being deployed in dozens of countries around the world.
  • The WHO has already given emergency use listing to the vaccines being made by Pfizer-BioNTech, Moderna, J&J, and the AstraZeneca jab being produced at sites in India and in South Korea. “
  • The WHO recommended that the two Sinopharm shots be taken three to four weeks apart.
  • The vaccine’s efficacy for symptomatic and hospitalised cases of COVID-19 was estimated to be 79% when all age groups are combined.
  • The agency said few adults over 60 were enrolled in clinical trials of the vaccine, so its efficacy could not be estimated in that age group.
How it works?
  • The Sinopharm vaccine is an inactivated coronavirus vaccine, like Covaxin developed by Bharat Biotech India (BBIL) in collaboration with the National Institute of Virology (NIV).
  • Inactivated vaccines take the disease-carrying virus (in this case SARS-CoV-2) and kill it using heat, chemicals or radiation.
Significance
  • The objective is to make medicines, vaccines and diagnostics available as rapidly as possible to address the emergency, while adhering to stringent criteria of safety, efficacy and quality.
  • The assessment weighs the threat posed by the emergency as well as the benefit that would accrue from the use of the product against any potential risks.
Source: Indian Express

More Related Current Affairs View All

08 Aug

Concerns about Sulphur Dioxide

'Recently, the government decided to scale back its 2015 mandate requiring coal-based thermal plants to install flue gas desulphurisation (FGD) devices (clean-air equipment) that r

Read More

08 Aug

Prime Minister Internship Scheme

'Based on the review of the two pilot phases carried out for the PM Internship Scheme (PMIS), the Ministry of Corporate Affairs is planning to undertake certain tweaks in the schem

Read More

08 Aug

Are the Rohingya ‘refugees’?

'The Supreme Court will decide whether the Rohingya in India “are entitled to be declared as ‘refugees’” or whether they are “illegal entrants”.

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps